PatientID	Patient age at initial diagnosis Ge	Stage at initial diagnosis	Treatment of primary disease	Metastatic treatments prior to biopsy	Patient status	Surival time from initial diagnosis
PANFR0383	76	Metastatic	None	Gemcitabine/Nab- paclitaxel/Anti- hepatocyte growth factor antibody	Deceased	302
PANFR0473Li and PANFR0473Lu	63	Metastatic	None	FOLFIRINOX; Niraparib; PANFR0473Lu also post-Gemcitabine/Nab- paclitaxel	Deceased	1034
PANFR0489 and PANFR0489R2	67	Localized	Whipple; FOLFOX/Nab- paclitaxel; Capecitabine + radiation	Gemcitabine/Nab- paclitaxel; Gemcitabine; 5-FU/Liposomal irinotecan; FOLFOX	Deceased	2068
PANFR0526	72	Metastatic	None	None	Deceased	10
PANFR0543	65	Metastatic	None	None	Deceased	120
PANFR0545	75	Metastatic	None	None	Deceased	94
PANFR0552	49	Localized	FOLFIRINOX; Whipple; Gemcitabine/Nab- paclitaxel	None	Deceased	536
PANFR0557	44	Localized	Distal pancreatectomy; Gemcitabine/ Capecitabine	FOLFIRINOX; FOLFIRI	Deceased	1291
PANFR0562	76	Metastatic	None	None	Deceased	111
PANFR0575	79	Metastatic	None	None	Deceased	32
PANFR0576	63	Metastatic	None	None	Deceased	159
PANFR0578	62	Metastatic	None	FOLFIRINOX; Lung metastatectomy; FOLFIRINOX; 5-FU + radiation; Olaparib; Whipple	Alive	2068
PANFR0580	53	Metastatic	None	None	Alive	883
PANFR0583	61	Metastatic	None	None	Deceased	52
PANFR0588	71	Metastatic	None	None	Deceased	227
PANFR0592	37	Locally advanced 	FOLFIRINOX; Whipple 	None	Deceased	376
PANFR0593	63	Localized	None	None	Alive	199 (lost to follow up)
PANFR0598	75	Metastatic	None	None	Alive	817
PANFR0604	67	Metastatic	FOLFIRINOX	FOLFIRINOX; 	Deceased	952
PANFR0605	75	Metastatic	None	None	Deceased	322
PANFR0631	66	Metastatic	None	None	Alive	724
PANFR0635	76	Metastatic	None	None	Alive	744
PANFR0637	65	Metastatic	None	None	Deceased	149

